Literature DB >> 1571075

Lithium-induced delirium with therapeutic serum lithium levels: a case report.

A S Brown1, J Rosen.   

Abstract

Lithium-induced delirium occurring in geriatric patients with serum lithium levels that are within the "therapeutic" range (less than 1.5 mEq/L) has been described in the literature. We present a case that illustrates three major issues regarding this syndrome: (1) differentiating lithium-induced delirium from a recurrence of a chronic psychiatric disorder; (2) the use of the electroencephalogram in supporting this diagnosis; and (3) factors that may increase a patient's vulnerability to delirium while on lithium. A brief review of the most relevant literature is then presented. We conclude that lithium-induced neurotoxicity should be suspected in any patient receiving lithium who develops delirium, regardless of the serum level, and that immediate discontinuation of the medication be considered.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1571075     DOI: 10.1177/002383099200500109

Source DB:  PubMed          Journal:  J Geriatr Psychiatry Neurol        ISSN: 0891-9887            Impact factor:   2.680


  3 in total

Review 1.  Drug-induced cognitive impairment in the elderly.

Authors:  A R Moore; S T O'Keeffe
Journal:  Drugs Aging       Date:  1999-07       Impact factor: 3.923

Review 2.  An approach to drug induced delirium in the elderly.

Authors:  K Alagiakrishnan; C A Wiens
Journal:  Postgrad Med J       Date:  2004-07       Impact factor: 2.401

3.  Lithium and tricyclic antidepressant-induced delirium presenting with prominent dyspraxia: case report.

Authors:  David Hayward; Barrat Luft
Journal:  Ther Adv Psychopharmacol       Date:  2012-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.